IFP Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.6K Buy
246
+121
+97% +$6.22K ﹤0.01% 3301
2026
Q1
$7.41K Sell
125
-138
-52% -$8.95K ﹤0.01% 3313
2025
Q4
$16.2K Sell
263
-36
-12% -$2.2K ﹤0.01% 2825
2025
Q3
$18.7K Buy
299
+226
+310% +$15.7K ﹤0.01% 2609
2025
Q2
$10.5K Buy
73
+63
+630% +$5.27K ﹤0.01% 2889
2025
Q1
$1.55K Buy
+10
New +$820 ﹤0.01% 3226
2024
Q4
Hold
0
3556
2024
Q3
Sell
-11
Closed -$757 3412
2024
Q2
$757 Hold
11
﹤0.01% 3031
2024
Q1
$798 Buy
+11
New +$735 ﹤0.01% 2898
2023
Q1
Sell
-235
Closed -$12K 4141
2022
Q4
$12K Sell
235
-4
-2% -$229 ﹤0.01% 3279
2022
Q3
$24K Buy
239
+11
+5% +$609 ﹤0.01% 2930
2022
Q2
$23K Hold
228
﹤0.01% 2728
2022
Q1
$23K Buy
+228
New +$13.2K ﹤0.01% 2728
2020
Q2
Sell
-173
Closed -$6.92K 2896
2020
Q1
$6K Buy
+173
New +$6.72K ﹤0.01% 2000
2019
Q1
Sell
-1,606
Closed -$49K 3111
2018
Q4
$49K Sell
1,606
-54
-3% -$1.97K ﹤0.01% 1628
2018
Q3
$63K Hold
1,660
﹤0.01% 1766
2018
Q2
$64K Buy
1,660
+708
+74% +$23.9K ﹤0.01% 1768
2018
Q1
$42K Hold
952
﹤0.01% 1921
2017
Q4
$42K Buy
952
+67
+8% +$3.05K ﹤0.01% 1942
2017
Q3
$44K Sell
885
-31
-3% -$1.58K ﹤0.01% 2067
2017
Q2
$48K Buy
916
+84
+10% +$4.5K ﹤0.01% 1996
2017
Q1
$46K Sell
832
-14
-2% -$772 ﹤0.01% 1981
2016
Q4
$44K Hold
846
﹤0.01% 1967
2016
Q3
$41K Sell
846
-408
-33% -$20.6K ﹤0.01% 1943
2016
Q2
$69K Buy
+1,254
New +$69.1K ﹤0.01% 1567
2016
Q1
Sell
-739
Closed -$38K 3102
2015
Q4
$38K Buy
+739
New +$36.7K ﹤0.01% 1779

Other funds holding PBH

IFP Advisors's PBH Position: Q2 2026 in Review

IFP Advisors increased its Prestige Consumer Healthcare (PBH) stake by 97% in Q2 2026, buying an estimated $6.22K and bringing the position to 246 shares worth $11.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3301.

IFP Advisors first reported a position in PBH in Q4 2015 and has held it in 25 quarters since. The position peaked at $69K in Q2 2016. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • IFP Advisors held 246 shares of Prestige Consumer Healthcare worth $11.6K as of Q2 2026.
  • IFP Advisors bought 121 Prestige Consumer Healthcare shares in Q2 2026, an estimated $6.22K.
  • Prestige Consumer Healthcare made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3301 holding.
  • IFP Advisors first reported a position in Prestige Consumer Healthcare in Q4 2015 and has held it in 25 quarters since.
  • IFP Advisors's Prestige Consumer Healthcare position peaked at $69K in Q2 2016.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.